Long-Term Follow-Up in Patients With Acute Myocardial Infarction Cohort
NCT ID: NCT05862103
Last Updated: 2025-09-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
15000 participants
OBSERVATIONAL
2022-12-21
2026-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Incidence Rate of Heart Failure After Acute Myocardial Infarction With Optimal Treatment
NCT03297164
Survival and cArdiovascular eVents in Patients With Acute Myocardial Infarction
NCT06489080
Transcriptome Study of Acute Myocardial Infarction
NCT03158597
Routinely Deferred Versus Early Intervention in Elderly Patients With Non-ST-elevation Myocardial Infarction
NCT02900001
China Acute Myocardial Infarction Registry
NCT01874691
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
optimized group
the patients received at least one optimized treatment
Treatment Strategies
AMI emergency treatment process, pre-reperfusion medication, reperfusion strategy selection, and early cardiac rehabilitation after reperfusion
un-optimized group
the patients didn't receive optimized treatment
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Treatment Strategies
AMI emergency treatment process, pre-reperfusion medication, reperfusion strategy selection, and early cardiac rehabilitation after reperfusion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Telephone to obtain informed consent from the subjects/family members of the subjects.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yu Bo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yu Bo
Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bo Yu
Role: STUDY_CHAIR
The Second Affiliated Hospital of Harbin Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing An Zhen Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Beijing Chao-Yang Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Peking University First Hospital
Beijing, Beijing Municipality, China
Guangdong general hospital
Guangzhou, Guangdong, China
The first affiliated hospital of Guangxi medical university
Nanning, Guangxi, China
Second hospital of hebei medical university
Shijiazhuang, Hebei, China
Daqing Oil Field Hospital
Daqing, Heilongjiang, China
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
Zhongda Hospital Southeast University
Nanjing, Jiangsu, China
The Second Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
The Second Hospital of Jilin University
Changchun, Jilin, China
The econd Affiliated Hospital of Dalian Medical University
Dalian, Liaoning, China
General Hospital of Northern Theater Command of the Chinese People's Liberation Army
Shenyang, Liaoning, China
Xijing Hospital of Air Force Military Medical University
Xi’an, Shanxi, China
Xinqiao Hospital Army Medical University
Chongqing, Sichuan, China
The General Hospital of Tianjin Medical University
Tianjin, Tianjin Municipality, China
Tianjin Chest Hospital
Tianjin, Tianjin Municipality, China
First Affiliated Hospital of Xinjiang Medical University
Ürümqi, Xinjiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ning Tan
Role: primary
Lang Li
Role: primary
Zhe Meng
Role: primary
Genshan Ma
Role: primary
Yanqing Wu
Role: primary
Peng Qu
Role: primary
Bin Wang
Role: primary
Chunjie Li
Role: primary
Xiang Ma
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KY2022-266
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.